GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HLS Therapeutics Inc (OTCPK:HLTRF) » Definitions » Inventories, Other

HLTRF (HLS Therapeutics) Inventories, Other : $7.68 Mil (As of Sep. 2024)


View and export this data going back to 2010. Start your Free Trial

What is HLS Therapeutics Inventories, Other?

Other inventories including goods for resale, stocks in transit, consignment stocks, etc. HLS Therapeutics's other inventories for the quarter that ended in Sep. 2024 was $7.68 Mil.

HLS Therapeutics's quarterly other inventories declined from Mar. 2024 ($10.09 Mil) to Jun. 2024 ($8.80 Mil) and declined from Jun. 2024 ($8.80 Mil) to Sep. 2024 ($7.68 Mil).

HLS Therapeutics's annual other inventories declined from Dec. 2021 ($8.93 Mil) to Dec. 2022 ($8.90 Mil) but then increased from Dec. 2022 ($8.90 Mil) to Dec. 2023 ($9.53 Mil).


HLS Therapeutics Inventories, Other Historical Data

The historical data trend for HLS Therapeutics's Inventories, Other can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLS Therapeutics Inventories, Other Chart

HLS Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Other
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.06 10.63 8.93 8.90 9.53

HLS Therapeutics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Inventories, Other Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.75 9.53 10.09 8.80 7.68

HLS Therapeutics Inventories, Other Calculation

Other inventories including goods for resale, stocks in transit, consignment stocks, etc.


HLS Therapeutics Business Description

Traded in Other Exchanges
Address
10 Carlson Court, Suite 701, Etobicoke, ON, CAN, M9W 6L2
HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company products include Clozaril, Vascepa, CSAN Pronto, and others. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, and the United States, and the Rest of the world.